'India Pharma Week' Moves to Delhi-NCR in 2018
UBM India, India’s leading B2B exhibition organiser, is all set to bring in the third edition of appreciated India Pharma Week (IPW), a week-long celebration from December 10-14, 2018 alongside its flagship expo CPhI & P-MEC India (December 12-14, 2018) to North India. Unlike the previous editions organised in Mumbai across a number of venues, this year all the engagements of the IPW, which is also South Asia’s largest pharma event will be held at the India Expo Mart – Greater Noida, with all its attendant facilities.
Commemorating the 12 years of the CPhI & P-MEC India expo, the IPW will include more than 10 events and activities pertaining to the streams of business, knowledge, leadership, innovation, recognition and networking in the field of Pharma. Engagements include Pharma Leader’s Golf, Pre-Connect Congress, Plant Visit, Women in Pharma, India Pharma Awards, Networking Evening, the CPhI & P-MEC India Exhibition, a closed-door CEO Roundtable, among others.
According to Mr. Yogesh Mudras, Managing Director, UBM India, the shift to the Delhi-NCR region, “in close geographical proximity to the Centre, policy makers, consulates and government bodies will enhance our community building efforts as well as the creation of a robust pharma eco-system.”
Looking for chemical products? Let suppliers reach out to you!
2026-07-06
-
Life Sciences Industry Overview
The coverage spans the global life sciences industry across pharmaceuticals and food & nutrition, tracking the shift from lowest-cost sourcing to supply continuity, quality, and risk management, along with product trends and the growing edge of differentiated, globally capable players.Published in: June.2026
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Pharma Quality Excellence Awards 2026 - Celebration and Conclusion
-
Pharma Quality Reimagined: Highlights from the 6th Annual Pharma GMP & Quality Management 2026
-
From Feedmill to Food System: VIV Europe 2026 Addresses the Industry's Most Critical Challenges
-
Beyond Compliance: Building Quality Maturity
-
Is the class solidified? From Biotech to Pharma
-
The IPO of the Largest Domestic Metronidazole API Manufacturer has Passed the Meeting
-
Progesterone Market Potential is Huge
-
PharmaReg AfriSummit
-
2022 PHARMA X FOOD X FINE CHEMICAL RAW MATERIALS MATCH MEETING Successfully Held!
-
KOREA PHARM & BIO 2021
Recommend Reading
-
BASF’s Price Increase Shows Pharma Excipients Are Still Exposed to Chemical Cost Pressure
-
FDA’s Warning to Compounders Raises the Stakes for API and Excipient Suppliers
-
Sun Pharma’s Ilumya Hits Primary Endpoint in Two Phase 3 Trials for Psoriatic Arthritis $681 Million Drug Shows Significant Improvement at Week 24
-
Lilly’s Indiana Investment Puts API Capacity at the Center of Obesity Drug Competition
-
Sanofi’s $2.2 Billion Dynavax Acquisition: Why Big Pharma Is Rebuilding the Global Vaccine Order
-
Calcium Propionate Uses: Food Preservation & Industrial Applications
-
This Week's Styrene Market Slightly Declined (9.8-9.12) in China
-
This Week TDI Market Stopped Falling and Rose (9.8-9.12)
-
Spot market negotiations are lukewarm, acrylonitrile prices rise and then fall
-
This Week's Pure Benzene Market Prices Slightly Increased in China (9.8-9.12)